Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Unknown 3Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Spinal Cord Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hemangioma, Capillary 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 291Drug Therapy 277Bevacizumab 249apatinib 247camrelizumab 219Etoposide 201Irinotecan 183Doxorubicin 181Leucovorin 164Dexamethasone 161pembrolizumab 155Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Atenolol × Clear all
NCT05106179 2021-11-03

The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma

Center for Vascular Pathology, Moscow

Phase 4 Unknown
1,000 enrolled
CNS

Spinal Cord Neoplasms

NCT03237637 2018-08-28

Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas

Post Graduate Institute of Medical Education and Research, Chandigarh

Phase 3 Unknown
60 enrolled

Hemangioma, Capillary

NCT01795235 2013-02-20

Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones

University of Virginia

Phase NA Unknown
6 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡